Fed. Circ. Won't Let Jazz Keep System Patent In Orange Book
By Dani Kass · February 24, 2023, 7:43 PM EST
Jazz Pharmaceuticals must remove a patent from the Orange Book listing for its blockbuster narcolepsy drug Xyrem, as it covers neither the drug itself nor a method of using it, the...
To view the full article, register now.